Global consulting firm McKinsey & Company on Thursday reached a $573 million settlement with 49 state attorneys general and the District of Columbia related to consulting services it provided to pharmaceutical companies that directly contributed to the opioid epidemic.
The complaint describes how, from 2004 to 2019, McKinsey provided consulting services to opioid manufacturers—including OxyContin maker Purdue Pharma—and designed marketing schemes that directly contributed to the opioid crisis. According to the complaint, McKinsey allegedly advised Purdue on how to increase OxyContin sales “through physician targeting and specific messaging to prescribers.”
